Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals

Medical Mycology

Volumn 44, Issue 3, 2006, Pages 261-266

  Brito, Ligia R ^a,c   Guimarães, Thaís ^a,b   Nucci, Marcio ^e   Rosas, Robert C ^a,d   Paula Almeida, Leila ^a   Da Matta, Daniel A ^a   Colombo, Arnaldo L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b HOSPITAL DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO   (Brazil)

^c HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

^d Casa de Saúde Santa Marcelina CSSM   (Brazil)

^e FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Antifungal resistance; Candida parapsilosis; Candidemia; Caspofungin; Nosocomial infection

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BRAZIL; CANCER CHEMOTHERAPY; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; FUNGUS TRANSMISSION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE ANALYSIS; NEUTROPENIA; OUTCOMES RESEARCH; PROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; FEMALE; FUNGEMIA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROSPECTIVE STUDIES;

CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; FUNGI;

EID: 33646848075     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780500421476     Document Type: Article

References (23)

1. Almirante, B and Rodriguez, D and Park, BJ and et al (2005) Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from to 2002 to 2003 J Clin Microbiol, 43, pp. 1829-1835.
2. Asmundsdottir, LR and Erlendsdottir, H and Gottfredsson, M. (2002) Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland J Clin Microbiol, 40, pp. 3489-3492.
3. Martin, D and Persat, F and Piens, MA and Picot, S. (2005) Candida species distribution in bloodstream cultures in Lyon, France, 1998-2001 Eur J Clin Microbiol Infect Dis, 24, pp. 329-333.
4. Pappas, PG and Rex, JH and Lee, J and et al (2003) A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients Clin Infect Dis, 37, pp. 634-643.
5. Roilides, E and Farmaki, E and Evdoridou, J and et al (2004) Neonatal candidiasis: Analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates Eur J Clin Microbiol Infect Dis, 23, pp. 745-750.
6. Lopez Sastre, JB and Coto Cotallo, GD and Fernandez, CB. (2003) Neonatal invasive candidiasis: A prospective multicenter study of 118 cases Am J Perinatol, 20, pp. 153-163.
7. Silva V and Diaz, MC and Febre, N. (2004) Invasive fungal infections in Chile: A multicenter study of fungal prevalence and susceptibility during a 1-year period Med Mycol, 42, pp. 333-339.
8. Pasqualotto AC and Nedel, WL and Machado, TS and Severo, LC. (2005) A comparative study of risk factors and outcome among outpatient-acquired and nosocomial candidaemia J Hosp Infect, 60, pp. 129-134.
9. Costa, SF and Marinho, I and Araujo, EA and et al (2000) Nosocomial fungaemia: A 2-year prospective study J Hosp Infect, 45, pp. 69-72.
10. Colombo, AL and Nucci, M and Salomao, R and et al (1999) High rate of non-albicans candidemia in Brazilian tertiary care hospitals Diagn Microbiol Infect Dis, 34, pp. 281-286.
11. Levin, AS and Costa, SF and Mussi, NS and et al (1998) Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers Diagn Microbiol Infect Dis, 30, pp. 243-249.
12. Nucci, M and Anaissie, E. (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis, 33, pp. 1959-1967.
13. Nucci, M and Colombo, AL and Silveira, F and et al (1998) Risk factors for death in patients with candidemia Infect Control Hosp Epidemiol, 19, pp. 846-850.
14. National Committee for Clinical Laboratory Standards. (2002) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard M38:A. Wayne PA: National Committee for Clinical Laboratory Standards.
15. Nguyen, MH and Clancy, CJ and Yu, VL and et al (1998) Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia J Infect Dis, 177, pp. 425-430.
16. Tortorano, AM and Peman, J and Bernhardt, H and et al (2004) Epidemiology of candidaemia in Europe: Results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study Eur J Clin Microbiol Infect Dis, 23, pp. 317-322.
17. Pfaller, MA and Jones, RN and Doern, GV and et al (1998) International surveillance of bloodstream infections due to Candida species: Frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group J Clin Microbiol, 36, pp. 1886-1889.
18. Girmenia, C and Martino, P and De, BF and et al (1996) Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains Clin Infect Dis, 23, pp. 506-514.
19. Safdar, A and Bannister, TW and Safdar, Z. (2004) The predictors of outcome in immunocompetent patients with hematogenous candidiasis Int J Infect Dis, 8, pp. 180-186.
20. Ostrosky-Zeichner, L and Rex, JH and Pappas, PG and et al (2003) Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States Antimicrob Agents Chemother, 47, pp. 3149-3154.
21. Pfaller, MA and Messer, SA and Bolmstrom, A. (1998) Evaluation of Etest for determining in vitro susceptibility of yeast isolates to amphotericin B Diagn Microbiol Infect Dis, 32, pp. 223-227.
22. Sarvikivi, E and Lyytikäinen, O and Soll, DR and et al (2005) Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit J Clin Microbiol, 43, pp. 2729-2735.
23. Mora-Duarte, J and Betts, R and Rotstein, C and et al (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis N Engl J Med, 347, pp. 2020-2029.